Stockscreener 앱 받기
2.04
4.62%
0.09
시간 외 거래:
2.04
전일 마감가:
$1.95
열려 있는:
$1.97
하루 거래량:
45,177
Relative Volume:
0.10
시가총액:
$5.32M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+12.09%
1개월 성능:
-12.07%
6개월 성능:
+29.94%
1년 성능:
+0.00%
1일 변동 폭
$1.91
$2.05
1주일 범위
$1.7425
$2.05
52주 변동 폭
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
명칭
Vivosim Labs Inc
전화
858-224-1000
주소
11555 SORRENTO VALLEY ROAD, SAN DIEGO
VIVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
2.04 | 5.09M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-12-13 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | 개시 | Raymond James | Outperform |
| 2015-08-11 | 다운그레이드 | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | 개시 | Jefferies | Buy |
| 2015-06-29 | 개시 | Piper Jaffray | Overweight |
모두보기
Vivosim Labs Inc 주식(VIVS)의 최신 뉴스
VivoSim Labs appoints Amar Sethi, M.D., Ph.D. as chief scientific officer - marketscreener.com
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - The Manila Times
VivoSim Labs appoints Amar Sethi as chief scientific officer By Investing.com - Investing.com India
Is VivoSim Labs Inc. (4OR) stock a top dividend aristocrat candidate2026 world cup usa national team quarterfinals top scorers build up play match prediction breakdown - Улправда
Is VivoSim Labs Inc. stock positioned for long term growth2026 world cup usa national team group stage top scorers high defensive line tactical prediction statistical analysis - Улправда
Target’s SoHo Store Opens Amid Strategic Expansion Efforts - StocksToTrade
Is VivoSim Labs Inc. stock affected by interest rate hikes2025 Dividend Review & Technical Entry and Exit Tips - Улправда
VivoSim Labs (NASDAQ:VIVS) Shares Up 2.6% – Should You Buy? - Defense World
Merger Talk: Why retail investors favor VivoSim Labs Inc. stockMarket Rally & Technical Analysis for Trade Confirmation - Улправда
Why retail investors favor VivoSim Labs Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - Улправда
Earnings Update: Why retail investors favor VivoSim Labs Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - Улправда
US Stocks Recap: Why VivoSim Labs Inc. stock could outperform in 2025Day Trade & Verified Technical Trade Signals - Улправда
Amar Akhtar Sethi Net Worth (2025) - GuruFocus
Trade Recap: Will VivoSim Labs Inc. stock benefit from automationGlobal Markets & High Win Rate Trade Tips - ulpravda.ru
Buyback Watch: Is VivoSim Labs Inc. stock attractive after correctionWeekly Market Report & Stepwise Entry/Exit Trade Alerts - Улправда
VivoSim Labs Stockholders Approve Directors and Governance Matters - TipRanks
Why VivoSim Labs Inc. stock could outperform in 2025Trade Volume Summary & Long-Term Safe Investment Ideas - Улправда
Is VivoSim Labs Inc. stock undervalued vs historical averagesJuly 2025 Selloffs & Free Growth Oriented Trading Recommendations - Улправда
Will VivoSim Labs Inc. stock benefit from automationPortfolio Value Summary & Verified Entry Point Detection - Улправда
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser
How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser
What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser
Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser
VivoSim Labs (VIVS) Competitors and Alternatives 2025 - MarketBeat
Will VivoSim Labs Inc. (4OR) stock beat revenue estimatesEarnings Growth Report & Real-Time Volume Analysis - Newser
Will VivoSim Labs Inc. (4OR) stock split increase liquidity - Newser
Momentum Shift: Is VivoSim Labs Inc. stock a safe investment in uncertain marketsWeekly Volume Report & Consistent Growth Stock Picks - moha.gov.vn
VivoSim Labs Inc. (VIVS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is VivoSim Labs Inc. (4OR) stock safe for risk averse investorsJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com
How VivoSim Labs Inc. (4OR) stock reacts to weak economy2025 AllTime Highs & Safe Entry Point Alerts - newser.com
What sentiment indicators say about VivoSim Labs Inc. stockWeekly Trend Report & Daily Technical Forecast Reports - newser.com
Relative strength of VivoSim Labs Inc. in sector analysisRecession Risk & Verified Entry Point Detection - newser.com
How VivoSim Labs Inc. (4OR) stock performs during market turbulenceJuly 2025 Fed Impact & Verified Momentum Watchlists - newser.com
Will VivoSim Labs Inc. stock benefit from commodity pricesWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com
Insider Sell Alert: David Gobel Sells 3,266 Shares of VivoSim La - GuruFocus
How supply chain issues affect VivoSim Labs Inc. stock2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
Vivosim Labs Inc (VIVS) 재무 분석
Vivosim Labs Inc (VIVS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):